Cigna Corporation (NYSE:CI)‘s stock had its “outperform” rating reiterated by Royal Bank Of Canada in a report issued on Friday. They currently have a $220.00 target price on the health services provider’s stock, up from their previous target price of $185.00. Royal Bank Of Canada’s price objective would suggest a potential upside of 10.89% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Deutsche Bank AG increased their price target on shares of Cigna Corporation from $175.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday, July 13th. Credit Suisse Group began coverage on shares of Cigna Corporation in a research report on Thursday. They issued an “outperform” rating and a $219.00 price target for the company. BidaskClub raised shares of Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Piper Jaffray Companies reissued a “buy” rating and issued a $191.00 price target on shares of Cigna Corporation in a research report on Sunday, September 17th. Finally, Morgan Stanley increased their price target on shares of Cigna Corporation from $184.00 to $188.00 and gave the stock an “overweight” rating in a research report on Monday, August 7th. Two investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Cigna Corporation has an average rating of “Buy” and a consensus target price of $197.06.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.47. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The firm had revenue of $10.38 billion during the quarter, compared to analyst estimates of $10.17 billion. During the same quarter in the prior year, the business posted $1.94 earnings per share. The company’s quarterly revenue was up 5.1% compared to the same quarter last year.

COPYRIGHT VIOLATION WARNING: “Royal Bank Of Canada Reaffirms “Outperform” Rating for Cigna Corporation (CI)” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/11/03/royal-bank-of-canada-reaffirms-outperform-rating-for-cigna-corporation-ci.html.

In other news, Director William D. Zollars sold 1,232 shares of the stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Jason D. Sadler sold 37,756 shares of the stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $176.16, for a total transaction of $6,651,096.96. Following the sale, the insider now directly owns 47,844 shares in the company, valued at $8,428,199.04. The disclosure for this sale can be found here. Insiders have sold 45,696 shares of company stock worth $8,070,481 over the last three months. 1.30% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Principal Financial Group Inc. grew its stake in shares of Cigna Corporation by 29.3% during the third quarter. Principal Financial Group Inc. now owns 529,935 shares of the health services provider’s stock valued at $99,066,000 after purchasing an additional 120,056 shares during the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of Cigna Corporation by 9.7% during the third quarter. Oregon Public Employees Retirement Fund now owns 73,028 shares of the health services provider’s stock valued at $13,652,000 after purchasing an additional 6,446 shares during the last quarter. United Asset Strategies Inc. bought a new stake in shares of Cigna Corporation during the third quarter valued at approximately $403,000. USA Financial Portformulas Corp bought a new stake in shares of Cigna Corporation during the third quarter valued at approximately $3,486,000. Finally, Trillium Asset Management LLC grew its stake in shares of Cigna Corporation by 1.1% during the third quarter. Trillium Asset Management LLC now owns 162,161 shares of the health services provider’s stock valued at $30,314,000 after purchasing an additional 1,747 shares during the last quarter. 88.23% of the stock is currently owned by institutional investors and hedge funds.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.